CMS needs to stay in its lane. FDA is in charge of drug approval, not CMS.
Editor's note · Context
Senator Collins emphasizes the FDA's role in drug approval over CMS.
Share & report
More from Susan Collins
I do not. But my focus is on getting an agreement on the money, on the funding.
Mr. President, before I begin my formal remarks, let me thank my neighbor from New Hampshire for organizing this bipartisan display of support for Ukraine. On February 24, 2022, without justification, without provocation, Russia launched a…
I'm very concerned about the impact on the state of Maine, on everything from our national parks to biomedical research. So this is a big problem.
Regardless of our views on the Fiscal Responsibility Act and accompanying implementation agreement, it is incumbent on all of us to follow the law as written—not as we would like it to be.





